Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
36 Leser
Artikel bewerten:
(0)

Global Radiotherapy Market is Poised to Reach Approximately $11.3 Billion by 2025

DUBLIN, March 23, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/hgb2dp/global) has announced the addition of the "Global Radiotherapy Market Analysis & Trends - Industry Forecast to 2025" report to their offering.

The Global Radiotherapy Market is poised to grow at a CAGR of around 6.7% over the next decade to reach approximately $11.3 billion by 2025.

This industry report analyzes the global markets for Radiotherapy across all the given segments on global as well as regional levels presented in the research scope. It presents historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report provides comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.

The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

Key Topics Covered:

1 Market Outline

2 Executive Summary

3 Market Overview

3.1 Current Trends

3.1.1 Growing digit of symposiums spreading awareness regarding the advantages of radiotherapy

3.1.2 Massive government and non government investments in Research and Development of cancer therapy

3.1.3 Recent Technological Developments of Radiotherapy

3.1.4 Growth Opportunities/Investment Opportunities

3.2 Drivers

3.3 Constraints

3.4 Industry Attractiveness

4 Radiotherapy Market, By Application 4.1 Gynecological Cancer 4.2 Spine Cancer 4.3 Breast Cancer 4.4 Head & Neck Cancer 4.5 Esophageal Cancer 4.6 Prostate Cancer 4.7 Lung Cancer ) 4.8 Penile Cancer 4.9 Colorectal Cancer 4.10 Cervical Cancer 4.11 Skin & Lip Cancer

5 Radiotherapy Market, By Product

5.1 Photon Radiations

5.2 Electron Beams

5.3 Gamma Rays

5.4 Ionizing Radiation

5.5 Non-Ionizing Radiation )

5.6 Neutron Beams

5.7 Particle Radiation

5.8 Proton Beams

5.8.1.1 Synchrotron

5.8.1.2 Cyclotron

5.9 Alpha and Beta Particles

5.10 Carbon Ions

5.11 X-rays

6 Radiotherapy Market, By Technology 6.1 Internal beam radio therapy 6.2 External beam radiation therapy 6.3 Systemic Radiation Therapy

7 Radiotherapy Market, By Geography

8 Leading Companies

- Angiodynamics Inc

- C.R. BARD Inc

- Coviden Plc

- Elekta AB

- GE Healthcare

- IBA Group

- Ion Beam Applications SA

- IsoRay Medical, Inc

- Mevion Medical Systems, Inc

- Mitsubishi Electric Corporation

- Nordion Inc

- Protom International Inc

- RaySearch Laboratories AB

- Siemens Healthcare

- Varian Medical Systems Inc

For more information visit

http://www.researchandmarkets.com/research/hgb2dp/global

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.